Good Health Can’t Wait.
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
<strong>Good</strong> <strong>Health</strong> <strong>Can’t</strong> <strong>Wait</strong>.<br />
Dr. Reddy’s Laboratories Limited<br />
19,800+<br />
Employees worldwide.<br />
(i) Preventable, (ii) Strategic and (iii)<br />
External risks. The Finance, Investment<br />
and Risk Management Council (or FIRM<br />
Council), is the Company’s management<br />
committee that helps the ERM function<br />
to prioritize organization-wide risks,<br />
review and steer mitigation efforts in line<br />
with the Company’s risk capacity and<br />
appetite. The FIRM council also oversees<br />
financial risk management and capital<br />
allocation decisions.<br />
REVIEWING THE STATUS OF<br />
MITIGATION AND RESIDUAL RISKS<br />
The Head of Dr. Reddy’s ERM team<br />
provides periodic updates to the FIRM<br />
Council and the Risk Committee of the<br />
Board of Directors. These include:<br />
(i) quarterly updates on the progress of<br />
mitigation of key risks, and (ii) specific<br />
initiatives carried out on risks during<br />
the year.<br />
During FY2015, the ERM team facilitated<br />
mitigation for certain geo-political and<br />
country risks, on forex and devaluation of<br />
currencies, on transfer risk and on people<br />
security. The team enhanced its key risk<br />
indicator tracking capabilities, developed<br />
a loss-data tracker and constructed a key<br />
learning’s summary for the year.<br />
On financial risk management, the team<br />
helped in developing a framework<br />
to enable making capital allocation<br />
decisions. It also assisted management<br />
in documentation and review of internal<br />
financial controls as required by the<br />
Companies Act, 2013.<br />
HUMAN RESOURCES<br />
Adjudged among the best employers<br />
in India, we at Dr. Reddy’s periodically<br />
renew our HR strategy to better engage<br />
with people and drive productivity across<br />
our 19,800-plus employees worldwide.<br />
Currently, our HR Strategy is designed to<br />
place our People Managers at the heart<br />
of all our employee practices. In this,<br />
we have stepped up our investments<br />
in leadership development and talent<br />
management programs.<br />
Our focus on leadership development<br />
and talent management was further<br />
strengthened this year. We continue to<br />
invest in our leadership development<br />
program which is built on the four tenets<br />
of ‘Lead Self, Lead Others, Lead Change<br />
and Lead Business’. The participants<br />
are beginning to show significant shifts<br />
in their development journey and the<br />
organization is benefiting through unique<br />
breakthrough projects that have been<br />
undertaken. We received CNBC ASIA’s<br />
India Talent Management Award this year<br />
as a recognition for our effective talent<br />
management practices.<br />
Dr. Reddy’s is an employer of choice<br />
for women. We lay special emphasis on<br />
helping our women colleagues grow<br />
professionally and personally as a part of<br />
our strategy to attract and retain the best<br />
talent in the industry. This year we made<br />
distinct progress in this area and rolled<br />
out our enabling policies and programs<br />
to help enhance gender diversity. Our<br />
focus on productivity also got an impetus<br />
as we benchmarked our productivity with<br />
industry and executed organizational<br />
design interventions that focused on<br />
delayering, reducing spans, sharply<br />
defining roles and agreeing on tighter<br />
manning norms. We also launched our<br />
new HR IT portal to help automate key<br />
HR processes.<br />
OUTLOOK<br />
The Company believes that its focus<br />
on profitable growth and targeting a<br />
leadership position in Global Generics<br />
and PSAI will create significant value in<br />
the near term.<br />
In GG, improving depth through<br />
portfolio expansion, cost leadership,<br />
consistent delivery of limited<br />
competition products and supply<br />
chain excellence should lead us to<br />
leadership positions in key markets. In<br />
PSAI, the objective is to be the partner<br />
of choice by creating compelling value<br />
52